VTAMA, a dermatology product acquired through the Dermavant acquisition, has shown promising results. In its second year on the market, VTAMA achieved sales of $75 million in fiscal year 2023.

VTAMA, a dermatology product acquired through the Dermavant acquisition, has shown promising results. In its second year on the market, VTAMA achieved sales of $75 million in fiscal year 2023.

At the same time, it is looking to offset Atozet’s LOE impact with strong growth from key products like Vtama, Emgality for fertility, and Nexplanon. Despite these hurdles, Organon & Co. (NYSE ...

But two new non-steroidal topicals were introduced this year — Dermavant Science’s Vtama and Arcutis Biotherapeutics’ Zoryve — and each one solves a long-time problem plaguing millions of ...

“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there JERSEY CITY, N.J., December 16, 2024--Organon's VTAMA (tapinarof) cream is a ...

It occurs most frequently in children, however, affecting up to 30% globally. VTAMA cream is a novel, aryl hydrocarbon receptor agonist in development as a once-daily, cosmetically elegant and ...

Investing in bonds may seem boring and not sexy like buying individual stocks, but bonds help provide diversification and stability to one’s portfolio. The FDA released results from its ...